-
公开(公告)号:EG27049A
公开(公告)日:2015-04-28
申请号:EGNA2005000507
申请日:2005-09-01
Applicant: ARRAY BIOPHARMA INC
Inventor: MUNSON MARK , MARESKA DAVID A , KIM YOUNGBOO , GRONEBERG ROBERT , RIZZI JAMES , RODRIGUEZ MARTHA , KIM GANGHYEOK , VIGERS GUY , RAO CHANG , BALACHARI DEVAN , HARVEY DARREN
IPC: A61K31/416 , A61K20060101 , A61K31/4745 , A61K31/503 , A61K31/675 , C07D20060101 , C07D231/56 , C07D261/20 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/12 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
Abstract: Compounds having the Formula: wherein Y, A, W, B, U, V, X and Ar 1 have the meanings given in the specification, which compounds are useful in therapy as p38-inhibitors.
-
公开(公告)号:NZ613235A
公开(公告)日:2015-04-24
申请号:NZ61323511
申请日:2011-12-13
Applicant: ARRAY BIOPHARMA INC
Inventor: BOYS MARK LAURENCE , DELISLE ROBERT KIRK , HICKEN ERIK JAMES , KENNEDY APRIL L , MARESKA DAVID A , MARMSATER FREDRIK P , MUNSON MARK C , NEWHOUSE BRAD , RAST BRYSON , RIZZI JAMES P , RODRIGUEZ MARTHA E , TOPALOV GEORGE T , ZHAO QIAN
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: The disclosure relates to a substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compound of formula (I) and pharmaceutically acceptable salts thereof in which the variables R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of type III receptor tyrosine kinases cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal.
-
公开(公告)号:DK1997809T3
公开(公告)日:2014-07-21
申请号:DK08164856
申请日:2004-02-25
Applicant: ARRAY BIOPHARMA INC
Inventor: MUNSON MARK , MARESKA DAVID A , GRONEBERG ROBERT , RIZZI JAMES , KIM GANGHYEOK , VIGERS GUY , RAO CHANG , BALACHARI DEVAN , KIM YOUNGBOO , RODRIGUEZ MARTHA , HARVEY DARREN
IPC: C07D231/56 , A61K20060101 , A61K31/416 , A61K31/4162 , A61K31/42 , A61K31/4745 , A61K31/503 , A61K31/675 , C07D20060101 , C07D261/20 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/12 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
-
公开(公告)号:UA103873C2
公开(公告)日:2013-12-10
申请号:UAA200813377
申请日:2004-02-25
Applicant: ARRAY BIOPHARMA INC
Inventor: MUNSON MARK C , MARESKA DAVID A , KIM YOUNGBOO , GRONEBERG ROBERT , RIZZI JAMES , RODRIGUEZ MARTHA , KIM GANGHYEOK , VIGERS GUY , RAO CHANG , BALACHARI DEVAN , HARVEY DARREN
IPC: C07D403/12 , A61K20060101 , A61K31/416 , A61K31/4745 , A61K31/503 , A61K31/675 , C07D20060101 , C07D231/56 , C07D261/20 , C07D401/14 , C07D403/04 , C07D405/12 , C07D413/12 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
Abstract: Соединенияформулы:,где Y, A, W, В, U, V, X и Arявляютсятакими, которыеуказаныв описании, соединенияиспользуютв терапиикакингибиторыр38.
-
公开(公告)号:PT1997810E
公开(公告)日:2013-11-07
申请号:PT08164860
申请日:2004-02-25
Applicant: ARRAY BIOPHARMA INC
Inventor: GRONEBERG ROBERT , MUNSON MARK , RIZZI JAMES , RODRIGUEZ MARTHA , MARESKA DAVID A , KIM GANGHYEOK , VIGERS GUY , RAO CHANG , HARVEY DARREN , KIM YOUNGBOO , BALACHARI DEVAN
IPC: C07D401/14 , A61K20060101 , A61K31/4745 , A61K31/503 , A61K31/675 , C07D20060101 , C07D231/56 , C07D261/20 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/12 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
-
公开(公告)号:DOP2009000155A
公开(公告)日:2010-09-15
申请号:DO2009000155
申请日:2009-06-24
Applicant: ARRAY BIOPHARMA INC
Inventor: GRONEBERG ROBERT D , MARESKA DAVID A , YOUNGBOO KIM , MUNSON MARK , RIZZI JAMES , RODRIGUEZ MARTHA , KIM GANGHYEOK , GUY VIGERS , CHANG RAO , DEVAN BALACHARI , DARREN HARVEY
IPC: A61K20060101 , A61K31/4745 , A61K31/503 , A61K31/675 , C07D20060101 , C07D231/56 , C07D261/20 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/12 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
Abstract: Compuestos que responden a la fórmula: donde Y, A, W, B, U, V, X y Ar1 se ajustan a la descripto en la memoria descriptiva. dichos compuestos son útiles para tratamientos terapéuticos como inhibidores p38.
-
公开(公告)号:AU2009225343A1
公开(公告)日:2009-11-05
申请号:AU2009225343
申请日:2009-10-15
Applicant: ARRAY BIOPHARMA INC
Inventor: MARESKA DAVID A , HARVEY DARREN , GRONEBERG ROBERT , BALACHARI DEVAN , KIM GANGHYEOK , RAO CHANG , KIM YOUNGBOO , MUNSON MARK , RIZZI JAMES , VIGERS GUY , RODRIGUEZ MARTHA
IPC: A61K31/4745 , A61K20060101 , A61K31/503 , A61K31/675 , C07D20060101 , C07D231/56 , C07D261/20 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/12 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
Abstract: Compounds having the Formula: wherein Y, A, W, B, U, V, X and Ar' have the meanings given in the specification, which compounds are useful in therapy as p38-inhibitors.
-
公开(公告)号:SI1606283T1
公开(公告)日:2009-04-30
申请号:SI200430987
申请日:2004-02-25
Applicant: ARRAY BIOPHARMA INC
Inventor: MUNSON MARK , MARESKA DAVID A , KIM YOUNGBOO , GRONEBERG ROBERT , RIZZI JAMES , RODRIGUEZ MARTHA , KIM GANGHYEOK , VIGERS GUY , RAO CHANG , BALACHARI DEVAN , HARVEY DARREN
IPC: C07D401/00 , A61K20060101 , A61K31/00 , A61K31/4745 , A61K31/503 , A61K31/675 , A61P35/00 , C07D20060101 , C07D231/00 , C07D231/56 , C07D261/00 , C07D261/20 , C07D401/14 , C07D403/00 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/00 , C07D413/12 , C07D471/00 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
-
公开(公告)号:ES2315641T3
公开(公告)日:2009-04-01
申请号:ES04714621
申请日:2004-02-25
Applicant: ARRAY BIOPHARMA INC
Inventor: MUNSON MARK , MARESKA DAVID A , KIM YOUNGBOO , GRONEBERG ROBERT , RIZZI JAMES , RODRIGUEZ MARTHA
IPC: C07D401/14 , A61K20060101 , A61K31/416 , A61K31/4162 , A61K31/4745 , A61K31/503 , A61K31/675 , A61P35/00 , C07D20060101 , C07D231/56 , C07D261/20 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/12 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
Abstract: Compuesto, que comprende solvatos y sales farmacéuticamente aceptables de los mismos, que se selecciona de entre: amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; [5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-il]-morfolin-4-il-metanona; [5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-il]-(4-metilpiperazin-1-il)-metanona; (1-bencilpiperidin-4-il)amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (2-bencilaminoetil)amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (2-piperidin-il-etil)amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (2-pirrolidin-1-il-etil)amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (3-morfolin-4-il-propil)amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (3-dimetilaminopropil)amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (2-dimetilaminoetil)amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; metil-(1-metilpiperidin-4-il)amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; [3-(metilfenilamino)-propil]amida del ácido 5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; terc-butil éster del ácido 3-{[5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carbonil]-amino}-pirrolidin-1-carboxílico; (2-dimetilaminoetil)amida del ácido 5-(4-fluorofenoxi)-1-(2,2,2-trifluoroetil)-1H-indazol-6-carboxílico; (2-dimetilaminoetil)amida del ácido 5-(4-fluorofenoxi)-1-metil-1H-indazol-6-carboxílico; (2-dimetilaminoetil)amida del ácido 5-(4-fluorofenoxi)-1H-indazol-6-carboxílico; éster metílico del ácido 4-amino-2-{[5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carbonil]-amino}butírico; éster metílico del ácido 4-amino-2-{[5-(4-fluorofenoxi)-1-(2,2,2-trifluoroetilo)-1H-indazol-6-carbonil]-amino}butírico; éster metílico del ácido 4-amino-2-{[5-(4-fluorofenoxi)-1-metil-1H-indazol-6-carbonil]-amino}butírico; (S)-N-(4-amino-1-hidroxibutan-2-il)-5-(4-fluorofenoxi)-1-isobutil-1H-indazol-6-carboxamida; (S)-metil 2-(5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carboxamida)-4-(dimetilamina)butanoato; (S)-5-(2,4-difluorofenoxi)-N-(4-(dimetilamino)-1-hidroxibutan-2-il)-1-isobutil-1H-indazol-6-carboxamida; (1-hidroximetil-3-isopropilaminopropil)amida del ácido (S)-5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; ácido (S)-2-{[5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carbonil]-amino}-4-dimetilaminobutírico; (1-hidroximetil-3-piperidin-1-ilpropil)amida del ácido (S)-5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (3-dimetilamino-1-dimetilcarbamoilpropil)amida del ácido (S)-5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (3-dimetilamino-1-metilcarbamoilpropil)amida del ácido (S)-5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (1-carbamoil-3-dimetilaminopropil)amida del ácido (S)-5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; [1-(2-dimetilaminoetil)-2-hidroxi-2-metilpropil]amida del ácido (S)-5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol- 6-carboxílico; {1-hidroximetil-3-[(2-metoxietil)metilamino]propil}amida del ácido (S)-5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; [3-dimetilamino-1-(2-hidroxietilcarbamoil)propil]amida del ácido (S)-5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-carboxílico; (3-dimetilaminopropil)amida del ácido 5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-sulfónico; (S)-metil 2-(5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-sulfonamida)-4-(dimetilamino)butanoato; [2-(1-metilpirrolidin-2-il)-etil]amida del ácido 5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-sulfónico; y (2-dimetilaminoetil)amida del ácido 5-(2,4-difluorofenoxi)-1-isobutil-1H-indazol-6-sulfónico.
-
公开(公告)号:DE602004016970D1
公开(公告)日:2008-11-20
申请号:DE602004016970
申请日:2004-02-25
Applicant: ARRAY BIOPHARMA INC
Inventor: MUNSON MARK , MARESKA DAVID A , KIM YOUNGBOO , GRONEBERG ROBERT , RIZZI JAMES , RODRIGUEZ MARTHA , KIM GANGHYEOK , VIGERS GUY , RAO CHANG , BALACHARI DEVAN , HARVEY DARREN
IPC: C07D401/14 , A61K20060101 , A61K31/416 , A61K31/4162 , A61K31/4745 , A61K31/503 , A61K31/675 , A61P35/00 , C07D20060101 , C07D231/56 , C07D261/20 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/12 , C07D471/02 , C07D471/04 , C07D487/02 , C07D491/02 , C07D498/02
Abstract: Compounds having the Formula: wherein Y, A, W, B, U, V, X and Ar 1 have the meanings given in the specification, which compounds are useful in therapy as p38-inhibitors.
-
-
-
-
-
-
-
-
-